Diagnosis and management of iron deficiency in CKD: A summary of the NICE guideline recommendations and their rationale

American Journal of Kidney Diseases

Volumn 67, Issue 4, 2016, Pages 548-558

  Ratcliffe, Laura E K ^a   Thomas, Wayne ^b   Glen, Jessica ^c   Padhi, Smita ^c   Pordes, Ben A J ^c   Wonderling, David ^c   Connell, Roy ^d   Stephens, Suzanne ^e   Mikhail, Ashraf I ^f   Fogarty, Damian G ^g   Cooper, Jan K ^h   Dring, Belinda ^d   Devonald, Mark A J ^d   Brown, Chris ^f   Thomas, Mark E ⁱ  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^c National Clinical Guideline Centre   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f ABERTAWE BRO MORGANNWG UNIVERSITY HEALTH BOARD   (United Kingdom)

^g ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^h Kidney Patient Association   (United Kingdom)

ⁱ UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anemia; chronic kidney disease (CKD); clinical practice guideline; diagnostic tests; erythropoietin; hemodialysis; hypersensitivity; inflammation; intravenous iron; iron deficiency; iron overload; iron therapy; National Institute for Health and Care Excellence (NICE)

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; FERRITIN; IRON; TRANSFERRIN;

ALLERGIC REACTION; ARTICLE; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DRUG MEGADOSE; ERYTHROCYTE COUNT; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HUMAN; HYPOXEMIA; INFLAMMATION; IRON BINDING CAPACITY; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; IRON THERAPY; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; RETICULOCYTE HEMOGLOBIN CONTENT; TRANSFERRIN BLOOD LEVEL; ANEMIA, IRON-DEFICIENCY; CHRONIC KIDNEY FAILURE; COMPLICATION; PHYSIOLOGY;

ANEMIA, IRON-DEFICIENCY; ERYTHROPOIETIN; HUMANS; IRON; META-ANALYSIS AS TOPIC; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY, CHRONIC;

EID: 84952915175     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.11.012     Document Type: Article

References (38)

1. National Clinical Guideline Centre. Anaemia management in chronic kidney disease: update 2015. NICE guideline 8. National Institute for Health and Care Excellence (NICE). Updated 2015. http://www.nice.org.uk/guidance/ng8. Accessed June 3, 2015.
2. S. Padhi, J. Glenn, B.A.J. Pordes, and M.E. Thomas Management of anaemia in chronic kidney disease: summary of updated NICE guidance BMJ 350 2015 h2258
3. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group KDIGO clinical practice guideline for anemia in chronic kidney disease Kidney Int Suppl 2 4 2012 279 335
4. F. Locatelli, P. Barany, A. Covic, and et al. Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement Nephrol Dial Transplant 28 6 2013 1346 1359
5. A.S. Kliger, R.N. Foley, D.S. Goldfarb, and et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD Am J Kidney Dis 62 5 2013 849 859
6. Chung M, Moorthy D, Hadar N, Salvi P, Iovin RC, Lau J. Biomarkers for assessing and managing iron deficiency anemia in late-stage chronic kidney disease. Comparative Effectiveness Review No. 83. AHRQ Publication No. 12(13)-EHC140-EF. Agency for Healthcare Research and Quality. Updated 2012. http://effectivehealthcare.ahrq.gov/ehc/products/295/1281/CER83-AnemiaBiomarkers-ExecutiveSummary-20121010.pdf. Accessed March 29, 2015.
7. A.C. Looker, P.R. Dallman, M.D. Carroll, E.W. Gunter, and C.L. Johnson Prevalence of iron deficiency in the United States JAMA 277 12 1997 973 976
8. J.Y. Yang, T.C. Lee, M.E. Montez-Rath, and et al. Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients J Am Soc Nephrol 23 3 2012 495 506
9. J.W. Eschbach, J.D. Cook, B.H. Scribner, and C.A. Finch Iron balance in hemodialysis patients Ann Intern Med 87 6 1977 710 713
10. F. Martin-del-Campo, C. Batis-Ruvalcaba, L. Gonzalez-Espinoza, and et al. Dietary micronutrient intake in peritoneal dialysis patients: relationship with nutrition and inflammation status Perit Dial Int 32 2 2012 183 191
11. H.P. Peters, C.M. Laarakkers, P. Pickkers, and et al. Tubular reabsorption and local production of urine hepcidin-25 BMC Nephrol 14 2013 70
12. L. Valenti, D. Girelli, G.F. Valenti, and et al. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients Clin J Am Soc Nephrol 4 8 2009 1331 1337
13. A.R. Nissenson, M.L. Dylan, R.I. Griffiths, H.T. Yu, and R.W. Dubois Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin Clin J Am Soc Nephrol 1 3 2006 505 510
14. V. Panichi, A. Rosati, R. Bigazzi, and et al. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study Nephrol Dial Transplant 26 8 2011 2641 2648
15. B.A. Ford, D.W. Coyne, C.S. Eby, and M.G. Scott Variability of ferritin measurements in chronic kidney disease; implications for iron management Kidney Int 75 1 2009 104 110
16. M. Rambod, C.P. Kovesdy, and K. Kalantar-Zadeh Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation Clin J Am Soc Nephrol 3 6 2008 1691 1701
17. National Clinical Guideline Centre. Anaemia management in chronic kidney disease: update 2015. NICE guideline 8: Appendices. National Institute for Health and Care Excellence (NICE). Updated 2015. http://www.nice.org.uk/guidance/NG8/evidence. Accessed June 3, 2015.
18. M.C.M. de Goeij, Y. Meuleman, S. van Dijk, and et al. Haemoglobin levels and health-related quality of life in young and elderly patients on specialized predialysis care Nephrol Dial Transplant 29 7 2014 1391 1398
19. D.W. Coyne, T. Kapoian, W. Suki, and et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study J Am Soc Nephrol 18 3 2007 975 984
20. Macdougall IC. KDIGO Controversies Conference on Iron Management in Chronic Kidney Disease. Iron Management: New Strategies Currently Under Investigation. Kidney Disease: Improving Global Outcomes. Updated 2014. http://www.kdigo.org/ControConf/Iron%20Management%202014/Macdougall-New%20Iron%20Management%20Strategies.pdf. Accessed May 23, 2015.
21. D. Richardson, C. Bartlett, and E.J. Will Optimizing erythropoietin therapy in hemodialysis patients Am J Kidney Dis 38 1 2001 109 117
22. C. Tolman, D. Richardson, C. Bartlett, and E. Will Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: a randomized clinical study J Am Soc Nephrol 16 5 2005 1463 1470
23. E.J. Will, D. Richardson, C. Tolman, and C. Bartlett Development and exploitation of a clinical decision support system for the management of renal anaemia Nephrol Dial Transplant 22 suppl 4 2007 iv31 iv36
24. BNF Paediatric Formulary Committee. British National Formulary for Children (BNFC) May 2015. BMJ Group, the Royal Pharmaceutical Society of Great Britain, and RCPCH Publications Ltd. Updated 2015. http://www.bnf.org/products/bnf-online/. Accessed May 24, 2015.
25. M.A. Brookhart, J.K. Freburger, A.R. Ellis, L. Wang, W.C. Winkelmayer, and A.V. Kshirsagar Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients J Am Soc Nephrol 24 7 2013 1151 1158
26. Zager P, Meyer KB, Ladik V, Paine S, Johnson D. Anemia management using computerized decision support. Updated 2013. http://www.nephrologynews.com/articles/computerized-decision-support-for-anemia-management-in-hemodialysis-patients. Accessed March 30, 2015.
27. M. Irving, J. Craig, M. Gallagher, and et al. Implementing iron management clinical practice guidelines in patients with chronic kidney disease having dialysis Med J Aust 185 6 2006 310 314
28. K. Yong, and L. Kairaitis Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort Nephrology (Carlton) 15 3 2010 288 293
29. European Medicines Agency. New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines. Updated 2013. http://www.ema.europa.eu/docs/en-GB/document-library/Referrals-document/IV-iron-31/WC500151308.pdf. Accessed March 4, 2015.
30. Committee for Medicinal Products for Human Use EMA. Annex II. Scientific conclusions and grounds for variation to the terms of the marketing authorisations. Overall summary of the scientific evaluation of intravenous iron containing medicinal products. European Medicines Agency. Updated 2013. http://www.ema.europa.eu/docs/en-GB/document-library/Referrals-document/IV-iron-31/WC500150773.pdf. Accessed March 4, 2015.
31. D.K. Wysowski, L. Swartz, B.V. Borders-Hemphill, M.R. Goulding, and C. Dormitzer Use of parenteral iron products and serious anaphylactic-type reactions Am J Hematol 85 9 2010 650 654
32. US Food and Drug Administration. FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol). Updated 2015. http://www.fda.gov/drugs/drugsafety/drugsafetypodcasts/ucm440823.htm. Accessed October 26, 2015.
33. C. Canavese, D. Bergamo, G. Ciccone, and et al. Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients Kidney Int 65 3 2004 1091 1098
34. P. Ferrari, H. Kulkarni, S. Dheda, and et al. Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease Clin J Am Soc Nephrol 6 1 2011 77 83
35. G. Rostoker, M. Griuncelli, C. Loridon, and et al. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study Am J Med 125 10 2012 991 999
36. K. Kalantar-Zadeh, D.L. Regidor, C.J. McAllister, B. Michael, and D.G. Warnock Time-dependent associations between iron and mortality in hemodialysis patients J Am Soc Nephrol 16 10 2005 3070 3080
37. D.C. Miskulin, N. Tangri, K. Bandeen-Roche, and et al. Intravenous iron exposure and mortality in patients on hemodialysis Clin J Am Soc Nephrol 9 11 2014 1930 1939
38. N.D. Vaziri Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation Am J Med 125 10 2012 951 952